Atossa Genetics to Present at Adoptive T-Cell Therapy Symposium – Molecular Medicine Tri-Conference on Thursday … – Nasdaq
|
Atossa Genetics to Present at Adoptive T–Cell Therapy Symposium – Molecular Medicine Tri-Conference on Thursday …
Nasdaq The presentation entitled "TRAP CAR-T and Related Cell Therapies: Can Local Delivery Solve Efficacy and Toxicity Challenges in Solid Tumor Immuno-Oncology?" will discuss Atossa's proprietary intraductal microcatheter technology and its potential to … |
